Catheter Over Needle vs Catheter Through Needle

April 18, 2016 updated by: Richard Edwards, Sir Charles Gairdner Hospital

Catheter Over Needle Technique Causes Less Leakage and Secondary Failure Than Catheter Through Needle Technique for Continuous Femoral Nerve Block

To randomize 108 patients undergoing knee replacement surgery to catheter through needle or catheter over needle femoral nerve blocks, then monitor the catheters for leakage to see if there is a difference.

Study Overview

Detailed Description

Background: Total Knee Replacement Surgery is a commonly performed procedure that causes significant post-operative pain. Continuous femoral nerve blocks are widely used for analgesia as part of a multimodal analgesic regimen for this surgery. They provide sustained analgesia which allows early physiotherapy for rehabilitation. Currently the most common technique for inserting catheters for continuous femoral nerve blocks is to feed a catheter though a needle (CTN) which has been placed close by the nerve. There is a significant rate of leak and dislodgement of these catheters which can lead secondary failure where the catheter is no longer providing analgesia by blocking the nerve (primary failure occurs when the nerve block catheter fails to provide any analgesia from the start). The system to be investigated has a catheter over the needle (CON) which is left in place after the needle is withdrawn. The proposed benefit of this is that there will be a reduction in leak rates and dislodgement. This is because using a CON technique means that the biggest hole will be the diameter of the catheter, rather than CTN where the biggest hole will be the diameter of the needle therefore allowing leak around the outside of the catheter.

Objectives: To ascertain whether or not the catheter over needle technique is superior to catheter through needle technique in terms of a leak rate.

Trial plan: To recruit 108 patients who are having total knee replacement surgery into the study and randomise them into having either CON or CTN continuous femoral nerve blocks.

Study Type

Interventional

Enrollment (Actual)

110

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Western Australia
      • Nedlands, Western Australia, Australia, 6009
        • Sir Charles Gairdner Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients presenting to Sir Charles Gairdner Hospital for elective, unilateral, primary total knee replacement.
  • Body mass index 18-40 kg/m2
  • American Society of Anaesthetists (ASA) grade I-III

Exclusion Criteria:

  • Allergy to local anaesthetic
  • Inability to cooperate
  • Inability to read, speak and understand English
  • Less than 18 years old

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Catheter Over Needle
The femoral nerve catheter used will be the "E-Catheter" (Pajunk) device which is a novel catheter over needle system.
Other Names:
  • Australian Therapeutic Goods Registry (ATGR) no: 133630
Active Comparator: Catheter through needle
The femoral nerve catheter used will be the "Sonolong" catheter (Pajunk) which is a traditional catheter through needle system.
Other Names:
  • Australian Therapeutic Goods Registry (ATGR) no: 133630

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Catheter leakage
Time Frame: 2 days post insertion
Any leakage around the catheter insertion site as assessed by visual inspection.
2 days post insertion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall rate of secondary failure as assessed by the acute pain service on days 1 and 2 post op.
Time Frame: 2 days
Secondary failure is when a nerve catheter that was previously working has ceased to provide analgesia.
2 days
Ease of insertion assessed by the inserting anaesthetist on a 5 point Likert scale.
Time Frame: intraoperative
Assess the anaesthetist's opinion on the ease of insertion of the different catheters
intraoperative
Needle visibility assessed by the inserting anaesthetist on a 5 point Likert scale.
Time Frame: intraoperative
Assessing the needle visibility in the two different catheter systems.
intraoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Richard M Edwards, MBBS, Sir Charles Gairdner Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2015

Primary Completion (Actual)

February 1, 2016

Study Completion (Actual)

February 1, 2016

Study Registration Dates

First Submitted

April 22, 2015

First Submitted That Met QC Criteria

April 30, 2015

First Posted (Estimate)

May 1, 2015

Study Record Updates

Last Update Posted (Estimate)

April 19, 2016

Last Update Submitted That Met QC Criteria

April 18, 2016

Last Verified

April 1, 2016

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nerve Block

Clinical Trials on E-Catheter (Pajunk)

3
Subscribe